Details werden geladen...
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | The Manila Times
BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 2,500,000 shares of common stock at a purchase price of $4.00 per share.
Ähnliche Seiten
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | The Manila Times
https://www.manilatimes.net/2026/06/19/tmt-newswire/globenewswire/cervomed-announces-10-million-registered-direct-offering-of-common-stock-priced-at-the-market-under-nasdaq-rules/2368752
Solidion Technology Announces $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules | The Manila Times
https://www.manilatimes.net/2026/06/08/tmt-newswire/globenewswire/solidion-technology-announces-35-million-private-placement-of-common-stock-priced-above-market-under-nasdaq-rules/2360337Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/bluejay-diagnostics-announces-closing-of-up-to-237-million-private-placement-priced-at-the-market-under-nasdaq-rules/2359920Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules | The Manila Times
https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/arcadia-biosciences-rkda-announces-closing-of-4-million-private-placement-priced-at-the-market-under-nasdaq-rules/2364775Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/jupiter-neurosciences-announces-closing-of-20-million-registered-direct-offering/2349715